BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 34815532)

  • 1. Anti-obesity drug discovery: advances and challenges.
    Müller TD; Blüher M; Tschöp MH; DiMarchi RD
    Nat Rev Drug Discov; 2022 Mar; 21(3):201-223. PubMed ID: 34815532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults.
    Tarazi MS; Touhamy S; Tchang BG; Shukla AP
    Expert Opin Pharmacother; 2021 Nov; 22(16):2199-2220. PubMed ID: 34165376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
    Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
    Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults.
    Bensignor MO; Kelly AS; Arslanian S
    Front Endocrinol (Lausanne); 2022; 13():1043650. PubMed ID: 36387846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effective Use of Anti-obesity Medications.
    Schmitz SH; Aronne LJ
    Gastroenterol Clin North Am; 2023 Dec; 52(4):661-680. PubMed ID: 37919019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
    Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
    Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation of weight management medications: implications for diabetes and CVD risk.
    Wharton S; Serodio KJ
    Curr Cardiol Rep; 2015 May; 17(5):35. PubMed ID: 25894803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination drugs for treating obesity.
    Greenway FL; Bray GA
    Curr Diab Rep; 2010 Apr; 10(2):108-15. PubMed ID: 20425569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
    Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
    [No Abstract]   [Full Text] [Related]  

  • 12. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy of Obesity: Limits and Perspectives.
    Rosa-Gonçalves P; Majerowicz D
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):349-364. PubMed ID: 30793263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK.
    Wilding JPH
    Clin Obes; 2018 Jun; 8(3):211-225. PubMed ID: 29689646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Type 2 diabetes; achieving weight loss.
    Hitman GA; Finer S
    Diabet Med; 2011 Jun; 28(6):627. PubMed ID: 21569083
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
    Burguera B; Ali KF; Brito JP
    Cleve Clin J Med; 2017 Jul; 84(7 Suppl 1):S39-S46. PubMed ID: 28708481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on obesity pharmacotherapy.
    Velazquez A; Apovian CM
    Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
    Pantalone KM; Smolarz BG; Ramasamy A; Baz Hecht M; Harty BJ; Rogen B; Griebeler ML; Borukh E; Young JB; Burguera B
    JAMA Netw Open; 2021 Jul; 4(7):e2116595. PubMed ID: 34255049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on pharmacotherapeutic strategies for obesity.
    Tchang BG; Tarazi MS; Aras M; Shukla AP
    Expert Opin Pharmacother; 2021 Jul; 22(10):1305-1318. PubMed ID: 33599159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.